Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 33
Filter
1.
Journal of Clinical Hepatology ; 38(9):2073-2077, 2022.
Article in Chinese | EMBASE | ID: covidwho-20245349

ABSTRACT

Objective To summarize and analyze the features of liver function in pediatric patients infected with Delta variant versus Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS - CoV - 2). Methods In this study,an analysis was performed for the liver function test results of the locally transmitted or imported pediatric patients with SARS - CoV - 2 infection during isolation who were admitted to Guangzhou Eighth People's Hospital,Guangzhou Medical University,since May 21,2021,and the clinical data and the constituent ratio of liver injury were compared between the pediatric patients infected with Delta variant and those infected with Omicron variant. The independent samples t - test or the Mann - Whitney U test was used for comparison of continuous data between two groups,and the chi - square test or the Fisher's exact test was used for comparison of categorical data between two groups. Results A total of 85 pediatric patients infected with SARS - CoV - 2 were enrolled,among whom there were 32 (37. 6%)pediatric patients infected with Delta variant and 53 (62. 4%)pediatric patients infected with Omicron variant,and there were no significant differences between the two groups in age,sex, body height,body weight,and comorbidities (all P > 0. 05). There were no significant differences between the two groups in alanine aminotransferase (ALT),aspartate aminotransferase (AST),alkaline phosphatase (ALP),gamma - glutamyl transpeptidase,total bilirubin,albumin,and cholinesterase (all P > 0. 05),and the pediatric patients infected with Omicron variant had a significantly higher level of total bile acid (TBA)than those infected with Delta variant (Z = - 2. 336,P = 0. 020). However,the median values of TBA were within the normal range and the ratios of abnormal TBA were no significant difference between the two groups (P > 0. 05). Among the 85 pediatric patients,10 (11. 8%)had a mild increase in liver function parameters,among whom 7 had an increase in TBA,1 had an increase in ALT, 1 had increases in ALT and AST,and 1 had an increase in ALP. The analysis of liver injury in the pediatric patients infected with Delta variant or Omicron variant showed that there was no significant difference in the constituent ratio of liver injury caused by the two variants (6. 3% vs 15. 1%,chi2 = 0. 691,P = 0. 406). Conclusion Mild liver injury is observed in pediatric patients infected with Delta and Omicron variants of SARS - CoV - 2,but further studies are needed to evaluate the long - term influence of such infection on liver function.Copyright © 2022 Editorial Board of Jilin University

2.
Journal of Clinical Hepatology ; 38(3):582-586, 2022.
Article in Chinese | EMBASE | ID: covidwho-20238727

ABSTRACT

Objective To investigate the clinical features of patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant infection and abnormal liver function in Guangdong Province, China. Methods The patients with SARS-CoV-2 Delta variant infection who belonged to the same chain of transmission in Guangdong Province (Guangzhou and Foshan) and were admitted to Guangzhou Eighth People's Hospital, Guangzhou Medical University from May 21 to June 18, 2021 were enrolled in this study, and the judgment criteria for liver function were alanine aminotransferase (male/female) > 50/40 U/L, aspartate aminotransferase > 40 U/L, total bilirubin > 26 mumol/L, gamma-glutamyl transpeptidase > 60 U/L, and alkaline phosphatase (ALK) > 125 U/L. Abnormality in any one item of the above criteria was defined as abnormal liver function, and such patients were included in analysis (the patients, aged < 18 years, who had a mild or moderate increase in ALP alone were not included in analysis). Clinical data were compared between the patients with normal liver function and those with abnormal liver function, and the etiology and prognosis of abnormal liver function were analyzed. The Mann-Whitney U test was used for comparison of continuous data between two groups;the chi-square test was used for comparison of categorical data between two groups. Results Among the 166 patients with SARS-CoV-2 Delta variant infection, 32 (19.3%) had abnormal liver function with mild-to-moderate increases in liver function parameters, and compared with the normal liver function group, the abnormal liver function group had a significantly higher proportion of critical patients (chi2=38.689, P < 0.001) and significantly higher age and inflammatory cytokines [C-reactive protein type, serum amyloid A, and interleukin-6 (IL-6)](all P < 0.05). Among the 32 patients with abnormal liver function, 13 patients had abnormal liver function on admission (defined as primary group), while 19 patients had normal liver function on admission but were found to have abnormal liver function by reexamination after treatment (defined as secondary group). For the primary group, the evidence of abnormal liver function was not found for 3 patients (3/13, 23.1%), and the possibility of toxic liver injury directly associated with SARS-CoV-2 infection was considered. Among the 19 patients in the secondary group, 9 (47.4%) had mild/common type and 10 (52.6%) had critical type, and all critical patients had the evidence of liver injury indirectly caused by the significant increases in C-reactive protein type, serum amyloid A, and IL-6 and hypoxemia;the evidence of abnormal liver function was not found for only 1 patient (1/19, 5.3%), and the possibility of toxic liver injury directly associated with SARS-CoV-2 infection was considered. All 32 patients with abnormal liver function had [JP2]significant reductions in liver function parameters after treatment including liver protection. Conclusion As for the patients with SARS-CoV-2 Delta variant infection who belong to the same chain of transmission in Guangdong Province, the critical patients show a significantly higher proportion of patients with abnormal liver function than the patients with other clinical types, and other factors except SARS-CoV-2 infection and indirect injury caused by SARS-CoV-2 infection are the main cause of liver injury.Copyright © 2022 Editorial Board of Jilin University. All rights reserved.

3.
Applied Sciences-Basel ; 13(10), 2023.
Article in English | Web of Science | ID: covidwho-20232298

ABSTRACT

Construction courses are characterized by a combination of theoretical and practical knowledge;however, the teaching of practical knowledge is often absent due to safety and cost considerations. VR can improve the teaching of practical knowledge by facilitating interactions between teachers and students through virtual means, regardless of location, which is a weakness of current lecture-based teaching, especially in the COVID-19 era. Therefore, this paper aims to evaluate the effect and discuss the prospect of VR in construction teaching, with a comparative study of 50 students who were evenly divided into two groups and taught using traditional teaching and VR teaching, respectively. This experiment shows that VR teaching improves the students' learning enthusiasm and satisfaction, especially in terms of practical knowledge. Additionally, students believe the combination of traditional and VR teachings can be more helpful in construction teaching. The findings of this research strengthened the advantages of VR in delivering practical knowledge in construction teaching.

4.
Advanced Intelligent Systems ; 2023.
Article in English | Web of Science | ID: covidwho-2309600

ABSTRACT

Rapid advances in wearable sensing technology have demonstrated unprecedented opportunities for artificial intelligence. In comparison with the traditional hand-held electrolarynx, a wearable and intelligent artificial throat with sound-sensing ability is a more comfortable and versatile method to assist disabled people with communication. Herein, a piezoresistive sensor with a novel configuration is demonstrated, which consists of polystyrene (PS) spheres as microstructures sandwiched between silver nanowires and reduced graphene oxide layers. In fact, changes in the device's conducting patterns are obtained by spay-coating the various weight ratios and sizes of the PS microspheres, which is a fast and convenient way to establish microstructures for improving sensitivity. The wearable artificial throat device also exhibits high sensitivity, fast response time, and ultralow intensity level detection. Moreover, the device's excellent mechanical-electrical performance allows it to detect subtle throat vibrations that can be converted into controllable sounds. In this case, an intelligent artificial throat is achieved by combining a deep learning algorithm with a highly flexible piezoresistive sensor to successfully recognize five different words (help, sick, patient, doctor, and COVID) with an accuracy exceeding 96%. Herein, new opportunities in voice control as well as other human-machine interface applications are opened.

5.
Chinese Journal of Diabetes Mellitus ; 12(7):535-538, 2020.
Article in Chinese | EMBASE | ID: covidwho-2296669
6.
Encyclopedia of Sensors and Biosensors: Volume 1-4, First Edition ; 1-4:474-488, 2022.
Article in English | Scopus | ID: covidwho-2294150

ABSTRACT

This article focuses on recent developments in microfluidic, lab on a chip technologies to enable point of care (POC) medical diagnostic devices, which can detect and monitor diseases outside of hospital settings. We provide a summary of the techniques to interface biological samples from macro-world to micro environments, on-chip processing steps to extract, isolate and transfer biomarkers of interest, and recent approaches to integrate advanced detection technologies in portable and easy to use devices. We highlight different applications of the proposed technologies, and review microfluidic methods proposed for the detection of infectious diseases such as COVID-19 caused by the novel Corona Virus. © 2023 Elsevier Ltd. All rights reserved

7.
Chinese Journal of Digestive Surgery ; 19(4):352-355, 2020.
Article in Chinese | EMBASE | ID: covidwho-2268819

ABSTRACT

In order to improve the cure rate of critically ill patients in Wuhan epidemic area and reduce the fatality rate, the state have dispatched medical staffs from the whole country to support Wuhan and treat critically ill patients in dedicated facilities. A medical team from the First Affiliated Hospital of Xi'an Jiaotong University, consisting of 133 medical staffs major in critical care medicine, respiralogy, infection, cardiology, and general surgery, entirely took over the critical care unit of the East Hospital of the Renmin Hospital of Wuhan University, and formed a multidisciplinary collaboration team with local medical staffs to treat patients together. Up to March 13th in 2020, the author's medical team has admitted a total of 109 patients, of which 48 had been discharged up on recovery. Critically ill patients with Corona Virus Disease 2019 mainly have elder age, comorbidities, complicated conditions, and difficult diagnosis and treatment. The author and the author's team combined with clinical practice, share experience and strategies of general surgery related issues in the treatment of critically ill patients, providing reference for collegues in general surgery.Copyright © 2020 by the Chinese Medical Association.

11.
Chinese Journal of Diabetes Mellitus ; 12(7):535-538, 2020.
Article in Chinese | EMBASE | ID: covidwho-2263393
12.
Chinese Journal of Evidence-Based Medicine ; 23(1):94-98, 2023.
Article in English | Scopus | ID: covidwho-2246822

ABSTRACT

The scientific research on prevention and control of coronavirus disease 2019 (COVID-19) has been a major and urgent task, of which clinical trials occupy a pivotal position in the entire prevention and control system. 204 relative clinical trials of traditional Chinese medicine (TCM) have been registered on Chinese Clinical Trial Registry. Through the analysis of all online public protocols of registered trials, it is found that the clinical studies of TCM in China showed lack of research foundation, tight time and heavy tasks, difficult clinical implementation, and disturbance by changes of the epidemic status. Based on these characteristics, this paper put forward several thoughts and suggestions on the quality management and design improvement for clinical trials of TCM preventing and treating COVID-19, in order to improve the quality of clinical trials in China, provide effective supports for the public health decision-making on the epidemic, and also give a reference for the prevention and control of epidemics in the future. © 2023 West China University of Medical Science. All rights reserved.

13.
Chinese Journal of Evidence-Based Medicine ; 23(1):94-98, 2023.
Article in Chinese | EMBASE | ID: covidwho-2237645

ABSTRACT

The scientific research on prevention and control of coronavirus disease 2019 (COVID-19) has been a major and urgent task, of which clinical trials occupy a pivotal position in the entire prevention and control system. 204 relative clinical trials of traditional Chinese medicine (TCM) have been registered on Chinese Clinical Trial Registry. Through the analysis of all online public protocols of registered trials, it is found that the clinical studies of TCM in China showed lack of research foundation, tight time and heavy tasks, difficult clinical implementation, and disturbance by changes of the epidemic status. Based on these characteristics, this paper put forward several thoughts and suggestions on the quality management and design improvement for clinical trials of TCM preventing and treating COVID-19, in order to improve the quality of clinical trials in China, provide effective supports for the public health decision-making on the epidemic, and also give a reference for the prevention and control of epidemics in the future. Copyright © 2023 West China University of Medical Science. All rights reserved.

14.
Chinese Journal of Evidence-Based Medicine ; 23(1):94-98, 2023.
Article in Chinese | EMBASE | ID: covidwho-2217484

ABSTRACT

The scientific research on prevention and control of coronavirus disease 2019 (COVID-19) has been a major and urgent task, of which clinical trials occupy a pivotal position in the entire prevention and control system. 204 relative clinical trials of traditional Chinese medicine (TCM) have been registered on Chinese Clinical Trial Registry. Through the analysis of all online public protocols of registered trials, it is found that the clinical studies of TCM in China showed lack of research foundation, tight time and heavy tasks, difficult clinical implementation, and disturbance by changes of the epidemic status. Based on these characteristics, this paper put forward several thoughts and suggestions on the quality management and design improvement for clinical trials of TCM preventing and treating COVID-19, in order to improve the quality of clinical trials in China, provide effective supports for the public health decision-making on the epidemic, and also give a reference for the prevention and control of epidemics in the future. Copyright © 2023 West China University of Medical Science. All rights reserved.

15.
China Tropical Medicine ; 22(9):811-815, 2022.
Article in Chinese | Scopus | ID: covidwho-2164283

ABSTRACT

Objective To investigate the impacts of vaccination with inactivated SARS-COV-2 vaccine on the clinical manifestations and serological responses of COVID-19 patients infected by Delta and Alpha variants. Methods Clinical and experimental data of 341 confirmed SARS-COV-2 patients were collected from The Eighth Affiliated Hospital of Guangzhou Medical University May 1- September 30, 2021. The subjects were divided into Delta and Alpha variant group according to virus variants, and were divided into vaccinated group and unvaccinated group according to whether they had received inactivated COVID-19 vaccine or not. The clinical manifestations and serological responses of patients with Delta and Alpha variant, and vaccinated and unvaccinated patients with Delta and Alpha variants were compared. Results Totally 253 patients were infected with Delta variant (103 vaccinated and 150 unvaccinated patients), and 88 patients were infected with Alpha variant (21 vaccinated and 67 unvaccinated patients). The proportion of asymptomatic infection in Delta variants group was significantly lower than that in Alpha variants group (P<0.01). Delta variant group of vaccination rates and vaccine breakthrough infection rate was 40.7% (103/253) and 22.9% (58/253), were higher than Alpha variant group was 23.9% (21/88) and 8.0% (7/88), difference was statistically significant (χ2= 8.009, 9.484, P<0.01). The proportion of cough and fever in Delta variant group was higher than that in Alpha variant group (both P<0.01), the peak viral load was higher than that of Alpha variant group (P<0.01), the virus duration was longer than that of Alpha variant group (P<0.01), the levels of SAA, CRP and IFN were higher than those of Alpha variant group (all P<0.05), CD4+T cell count was lower than that of Alpha variant group (P<0.05), IgG and IgM levels were lower than those of Alpha variant group (both P<0.01). The proportion of moderate COVID-19 in the vaccinated group was lower than that in the unvaccinated group (P<0.01). In these two variants, the peak viral load of vaccinated group was lower than that of the unvaccinated group (both P<0.01), the duration of virus was shorter than that of unvaccinated group (both P<0.01). The levels of SAA, CRP and IL-6 in the vaccinated group were lower than those in the unvaccinated group (all P<0.05), CD4+T cell level was higher than that of unvaccinated group (both P<0.05), IgG and IgM level were higher than those in unvaccinated group (both P<0.05). Conclusions Delta variant can lead to higher viral load and more severe disease course, which is associated with vaccine breakthrough infection. Inactivated vaccines for COVID-19 can reduce severe illness and death by reducing viral load, disease duration and inflammatory response through humoral and cellular immune mechanisms. © 2022 The authors.

16.
Frontiers in Immunology ; 12, 2021.
Article in English | Web of Science | ID: covidwho-2142042

ABSTRACT

While the immunogenicity of inactivated vaccines against coronavirus disease 2019 (COVID-19) has been characterized in several well-conducted clinical trials, real-world evidence concerning immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) raised by such vaccines is currently missing. Here, we comprehensively characterized various parameters of SARS-CoV-2-specific cellular and humoral immune responses induced by inactivated COVID-19 vaccines in 126 individuals under real-world conditions. After two doses of vaccination, S-receptor binding domain IgG (S-RBD IgG) and neutralizing antibody (NAb) were detected in 87.06% (74/85) and 78.82% (67/85) of individuals, respectively. Female participants developed higher concentrations of S-RBD IgG and NAb compared to male vaccinees. Interestingly, a longer dosing interval between the first and second vaccination resulted in a better long-term SARS-CoV-2 S-RBD IgG response. The frequencies of CD4+ T cells that produce effector cytokines (IFN-gamma, IL-2, and TNF-alpha) in response to stimulation with peptide pools corresponding to the SARS-CoV-2 spike (S), nucleocapsid (N) or membrane (M) protein were significantly higher in individuals received two doses of vaccine than those received one dose of vaccine and unvaccinated individuals. S, N, or M-specific CD4+ and CD8+ T cell responses were detectable in 95.83% (69/72) and 54.16% (39/72) of double-vaccinated individuals, respectively. The longitudinal analysis demonstrated that CD4+ T cell responses recognizing S, N, and M waned quickly after a single vaccine dose, but were boosted and became more sustained following a second dose. Overall, we provide a comprehensive characterization of immune responses induced by inactivated COVID-19 vaccines in real-world settings, suggesting that both humoral and cellular SARS-CoV-2 specific immunity are elicited in the majority of individuals after two doses of inactivated COVID-19 vaccines.

17.
Chinese Traditional and Herbal Drugs ; 53(20):6645-6652, 2022.
Article in Chinese | Scopus | ID: covidwho-2100335

ABSTRACT

In the prevention and treatment of novel coronavirus pneumonia, traditional Chinese medicine (TCM) has played an important role in blocking the development of the disease, reducing the severity and fatality rate, and also helping the functional recovery after infection, which has strongly promoted the development of TCM industry in China. The registration data from the Center for Drug Evaluation shows that 2021 is the largest year for TCM registration in the past 10 years. Pharmaceutical companies in Hubei, Shandong and Jilin are the most active. The target indications are focused on traditional dominant areas, such as digestion and metabolism diseases, respiratory system, more than 90% of registrations have been approved. Six out of 59 new have been reported for production and three drugs have been approved until the retrieval date. These data show that the enthusiasm for the development of TCM was significantly improved, new drug research has become more active. This positive new development trend will help to develop more high-quality TCM, greatly alleviate clinical needs and better protect people’s health. © 2022 Editorial Office of Chinese Traditional and Herbal Drugs. All rights reserved.

18.
Chinese Medicine and Culture ; 4(1):25-30, 2021.
Article in English | Scopus | ID: covidwho-2024703

ABSTRACT

Since the outbreak of coronavirus disease-2019 (COVID-19), traditional Chinese medicine (TCM) has fully displayed its strength and specialty and has played an important role in the prevention and treatment of the pandemic. Faced with the unexpected development of the pandemic, the Chinese government has responded quickly and attached great importance to the effect of TCM. Comprehensive therapy integrating Chinese and Western medicine has achieved remarkable success. To summarize and introduce the prevention and treatment of COVID-19 with TCM, this article covers the perspectives of policy guideline issue, clinical diagnosis participation, and scientific research progress. © 2020 Chinese Medicine and Culture. All rights reserved.

19.
Journal of Clinical Hepatology ; 38(3):582-586, 2022.
Article in Chinese | Scopus | ID: covidwho-1834994

ABSTRACT

Objective To investigate the clinical features of patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant infection and abnormal liver function in Guangdong Province, China. Methods The patients with SARS-CoV-2 Delta variant infection who belonged to the same chain of transmission in Guangdong Province (Guangzhou and Foshan) and were admitted to Guangzhou Eighth People's Hospital, Guangzhou Medical University from May 21 to June 18, 2021 were enrolled in this study, and the judgment criteria for liver function were alanine aminotransferase (male/female) > 50/40 U/L, aspartate aminotransferase > 40 U/L, total bilirubin > 26 μmol/L, gamma-glutamyl transpeptidase > 60 U/L, and alkaline phosphatase (ALK) > 125 U/L. Abnormality in any one item of the above criteria was defined as abnormal liver function, and such patients were included in analysis (the patients, aged < 18 years, who had a mild or moderate increase in ALP alone were not included in analysis). Clinical data were compared between the patients with normal liver function and those with abnormal liver function, and the etiology and prognosis of abnormal liver function were analyzed. The Mann-Whitney U test was used for comparison of continuous data between two groups;the chi-square test was used for comparison of categorical data between two groups. Results Among the 166 patients with SARS-CoV-2 Delta variant infection, 32 (19.3%) had abnormal liver function with mild-to-moderate increases in liver function parameters, and compared with the normal liver function group, the abnormal liver function group had a significantly higher proportion of critical patients (χ2=38.689, P < 0.001) and significantly higher age and inflammatory cytokines [C-reactive protein type, serum amyloid A, and interleukin-6 (IL-6)](all P < 0.05). Among the 32 patients with abnormal liver function, 13 patients had abnormal liver function on admission (defined as primary group), while 19 patients had normal liver function on admission but were found to have abnormal liver function by reexamination after treatment (defined as secondary group). For the primary group, the evidence of abnormal liver function was not found for 3 patients (3/13, 23.1%), and the possibility of toxic liver injury directly associated with SARS-CoV-2 infection was considered. Among the 19 patients in the secondary group, 9 (47.4%) had mild/common type and 10 (52.6%) had critical type, and all critical patients had the evidence of liver injury indirectly caused by the significant increases in C-reactive protein type, serum amyloid A, and IL-6 and hypoxemia;the evidence of abnormal liver function was not found for only 1 patient (1/19, 5.3%), and the possibility of toxic liver injury directly associated with SARS-CoV-2 infection was considered. All 32 patients with abnormal liver function had [JP2]significant reductions in liver function parameters after treatment including liver protection. Conclusion As for the patients with SARS-CoV-2 Delta variant infection who belong to the same chain of transmission in Guangdong Province, the critical patients show a significantly higher proportion of patients with abnormal liver function than the patients with other clinical types, and other factors except SARS-CoV-2 infection and indirect injury caused by SARS-CoV-2 infection are the main cause of liver injury. © 2022 Editorial Board of Jilin University. All rights reserved.

20.
Internet Research ; 2022.
Article in English | Scopus | ID: covidwho-1752277

ABSTRACT

Purpose: Understanding the privacy concerns of individuals in the adoption of contact tracing apps is critical for the successful control of pandemics like COVID-19. This paper explores the privacy paradox in the adoption of contact tracing apps in Australia. Design/methodology/approach: A comprehensive review of the related literature has been conducted, leading to the development of a conceptual model based on the privacy calculus theory and the antecedent-privacy concern-outcome framework. Such a model is then tested and validated using structural equation modelling on the survey data collected in Australia. Findings: The study shows that perceived benefit, perceived privacy risk and trust have significant influences on the adoption of contact tracing apps. It reveals that personal innovativeness and trust have significant and negative influences on perceived privacy risk. The study further finds out that personal innovativeness is insignificant to perceived benefit. It states that perceived ease of use has an insignificant influence on perceived privacy risk in the adoption of contact tracing apps. Originality/value: This study is the first attempt to use the privacy calculus theory and the antecedent–privacy concern–outcome framework for exploring the privacy paradox in adopting contact tracing apps. This leads to a better understanding of the privacy concerns of individuals in the adoption of contact tracing apps. Such an understanding can help formulate targeted strategies and policies for promoting the adoption of contact tracing apps and inform future epidemic control through effective contact tracing for better emergency management. © 2022, Emerald Publishing Limited.

SELECTION OF CITATIONS
SEARCH DETAIL